BR0113354A - Imunoterapia retroviral - Google Patents

Imunoterapia retroviral

Info

Publication number
BR0113354A
BR0113354A BR0113354-3A BR0113354A BR0113354A BR 0113354 A BR0113354 A BR 0113354A BR 0113354 A BR0113354 A BR 0113354A BR 0113354 A BR0113354 A BR 0113354A
Authority
BR
Brazil
Prior art keywords
cells
mammal
retroviral
produced
generally referred
Prior art date
Application number
BR0113354-3A
Other languages
English (en)
Inventor
Martin Leonard Ashdown
Original Assignee
Immunaid Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunaid Pty Ltd filed Critical Immunaid Pty Ltd
Publication of BR0113354A publication Critical patent/BR0113354A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"IMUNOTERAPIA RETROVIRAL". O presente inventor observou que pelo menos duas populações de células imunes são produzidas em resposta aos retrovírus que infectam mamíferos. Mais particularmente, o sistema imune de um mamífero infectado com um retrovírus é capaz de montar uma resposta imune contra o vírus através de um grupo de células aqui geralmente referidas como "células efetoras", no entanto, também é produzida uma segunda população de células que regula as "células efetoras", aqui geralmente referidas como "células reguladoras", que limitam a habilidade do mamífero para controlar ou erradicar efetivamente a infecção retroviral. Conformemente, a presente invenção utiliza essas observações para fornecer métodos de tratar um mamífero com uma infecção retroviral.
BR0113354-3A 2000-08-18 2001-08-16 Imunoterapia retroviral BR0113354A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9488A AUPQ948800A0 (en) 2000-08-18 2000-08-18 A vaccine strategy
PCT/AU2001/001019 WO2002013828A1 (en) 2000-08-18 2001-08-16 A retroviral immunotherapy

Publications (1)

Publication Number Publication Date
BR0113354A true BR0113354A (pt) 2003-07-08

Family

ID=3823543

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113354-3A BR0113354A (pt) 2000-08-18 2001-08-16 Imunoterapia retroviral

Country Status (12)

Country Link
EP (1) EP1311267B1 (pt)
JP (1) JP2004506015A (pt)
CN (1) CN100518739C (pt)
AU (2) AUPQ948800A0 (pt)
BR (1) BR0113354A (pt)
CA (1) CA2431954A1 (pt)
DK (1) DK1311267T3 (pt)
ES (1) ES2389897T3 (pt)
NZ (1) NZ524280A (pt)
PT (1) PT1311267E (pt)
WO (1) WO2002013828A1 (pt)
ZA (1) ZA200301694B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS065002A0 (en) * 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
AUPS054702A0 (en) 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
AU2004283322B2 (en) * 2003-10-24 2010-09-16 Biotempus Pty Ltd Method of therapy
BRPI0415533A (pt) * 2003-10-24 2006-12-26 Immunaid Pty Ltd método de terapia
US20080248022A1 (en) * 2004-09-08 2008-10-09 Immunaid Pty Ltd Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
ES2548508T3 (es) 2009-05-27 2015-10-19 Biotempus Limited Métodos de tratamiento de enfermedades
CN104013959A (zh) * 2014-05-21 2014-09-03 郭和友 逆转录抑制剂和免疫抗体细胞三联合疗法
CN108543225A (zh) * 2018-04-03 2018-09-18 江西汉江科技发展有限公司 一种提高hiv患者cd4+t淋巴细胞并降低病载的近红外led理疗设备及其应用
CN111701016A (zh) * 2020-06-28 2020-09-25 张全志 逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120296A1 (de) * 1991-06-28 1992-03-19 Regina Tilgner Rein pflanzliches kombinationspraeparat - gegen aids

Also Published As

Publication number Publication date
ES2389897T3 (es) 2012-11-02
JP2004506015A (ja) 2004-02-26
CN100518739C (zh) 2009-07-29
EP1311267A4 (en) 2007-10-24
EP1311267B1 (en) 2012-06-20
CN1469746A (zh) 2004-01-21
DK1311267T3 (da) 2012-09-10
AUPQ948800A0 (en) 2000-09-07
PT1311267E (pt) 2012-09-24
WO2002013828A1 (en) 2002-02-21
NZ524280A (en) 2004-09-24
AU2001283682A1 (en) 2002-02-25
ZA200301694B (en) 2004-03-01
EP1311267A1 (en) 2003-05-21
CA2431954A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
BR0012768A (pt) Sistema de células de combustìvel
BR0113354A (pt) Imunoterapia retroviral
BR0318206A (pt) sistema extensìvel de contexto de usuário para entrega de notificações
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
BR0203650A (pt) Estentor de auto-articulação
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
DE69734882D1 (de) Dna immunisierung gegen chlamydia infektion
BR0207733A (pt) Processo para a regulação de um processo termodinâmico, especialmente de um processo de combustão
TR199701531T1 (xx) Ektoparazit �ld�r�c� bile�imler.
BR0301945A (pt) Cassete cirúrgico
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BR9910359A (pt) Proteìna hìbrida para inibição de desgranulação de mastócitos e seu uso
BR112021019412A2 (pt) Membro estrutural
TR200000098T2 (tr) Yüksek seviyede avidin ekspresyonuyla eril kısırlığın bitkilerde indüksiyonu.
BR112023002932A2 (pt) Vetores de adenovírus e métodos para uso de vetores de adenovírus
BR0003072A (pt) Fechadura de cilindro dotada de meios de orientação magneticamente operados
ATE244215T1 (de) Flüssigkristalline verbindungen
PT84640B (pt) Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
BR0307868A (pt) Estratégia para imunoterapia retroviral
BR0308810A (pt) Células hospedeiras tendo propriedades melhoradas de sobrevivência celular e métodos para gerar tais células
BR112023002724A2 (pt) Neoantígenos ras e seus usos
NO940810L (no) Behandling av virusinfeksjoner
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
Sistermans et al. Co-localization and functional coupling of creatine kinase B and gastric H+/K+-ATPase on the apical membrane and the tubulovesicular system of parietal cells

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.